Articles published by GlobeNewswire
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
October 17, 2025
Via GlobeNewswire
Tickers
IOVA
PyroGenesis Announces Repricing and Extension to Term of Warrants
October 17, 2025
From PyroGenesis Inc.
Via GlobeNewswire
CCH Holdings Ltd Announces Full Exercise of Over-Allotment Option
October 17, 2025
From CCH Holdings Ltd
Via GlobeNewswire
Tickers
CCHH
From Rackspace US, Inc.
Via GlobeNewswire
Tickers
RXT
Rivalry Closes Second Tranche of Private Placement
October 17, 2025
From Rivalry Corp.
Via GlobeNewswire
Gyrodyne Announces Agreement with Star Equity Fund
October 17, 2025
From Gyrodyne, LLC
Via GlobeNewswire
Tickers
GYRO
Credicorp Ltd.: Credicorp’s “3Q25 quiet period”
October 17, 2025
Via GlobeNewswire
Tickers
BAP
From Value Line, Inc.
Via GlobeNewswire
Tickers
VALU
Ferrellgas, L.P. Announces Pricing of Senior Notes Offering
October 17, 2025
Via GlobeNewswire
Tickers
FGPR
4DMT Announces New Employment Inducement Grants
October 17, 2025
Via GlobeNewswire
Tickers
FDMT
MotorTrend Reveals the 2026 Car of the Year with YourUpdateTV
October 17, 2025
From D S Simon
Via GlobeNewswire
BROAD ARROW’S WYNN LAS VEGAS AUCTION FEATURES SOUGHT-AFTER CARS FOR EVERY COLLECTOR’S TASTE
October 17, 2025
From Broad Arrow Auctions
Via GlobeNewswire
Tickers
HGTY
From Lexitas
Via GlobeNewswire
UMKC Launches Record-Breaking Campaign to Transform the Future
October 17, 2025
From UMKC
Via GlobeNewswire
Sify Infinit Spaces files Draft Red Herring Prospectus in India
October 17, 2025
Via GlobeNewswire
Tickers
SIFY
Via GlobeNewswire
Tickers
IPG
Five Star Bancorp Declares Third Quarter Cash Dividend
October 17, 2025
From Five Star Bank
Via GlobeNewswire
Tickers
FSBC
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.